Show simple item record

dc.contributor.authorOffice of Marketing and Communications. Media Relations
dc.date.accessioned2018-06-07T18:39:06Z
dc.date.available2018-06-07T18:39:06Z
dc.date.issued2018-05-23
dc.identifier.urihttps://hdl.handle.net/1813/57299
dc.description.abstractThis news item is about: A Cornell-based biotechnology startup is developing a new product for toxicity screening. Heidi Reesink from the College of Veterinary Medicine is discovering new molecules associated with osteoarthritis in horses, while another researcher is understanding how ripening tomatoes acquire their color and flavor. These are a few projects that are benefitting from the launch of the Cornell Institute of Biotechnology's new Metabolomics core facility, which opened in January.
dc.language.isoen_US
dc.publisherCornell University, College of Veterinary Medicine
dc.subjectCornell University. College of Veterinary Medicine -- Periodicals.
dc.subjectReesink, Heidi
dc.title2018 CVM News: New metabolomics core facility enables new science
dc.typearticle


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics